GB1457400A - Pharmaceutical compositions containing 2-substituted quinoxa lines - Google Patents

Pharmaceutical compositions containing 2-substituted quinoxa lines

Info

Publication number
GB1457400A
GB1457400A GB3198676A GB3198676A GB1457400A GB 1457400 A GB1457400 A GB 1457400A GB 3198676 A GB3198676 A GB 3198676A GB 3198676 A GB3198676 A GB 3198676A GB 1457400 A GB1457400 A GB 1457400A
Authority
GB
United Kingdom
Prior art keywords
substituted
compositions containing
alkyl
quinoxa
lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3198676A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Publication of GB1457400A publication Critical patent/GB1457400A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB3198676A 1972-11-20 1973-11-14 Pharmaceutical compositions containing 2-substituted quinoxa lines Expired GB1457400A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30816872A 1972-11-20 1972-11-20
US41021473A 1973-10-26 1973-10-26

Publications (1)

Publication Number Publication Date
GB1457400A true GB1457400A (en) 1976-12-01

Family

ID=26976126

Family Applications (2)

Application Number Title Priority Date Filing Date
GB3198676A Expired GB1457400A (en) 1972-11-20 1973-11-14 Pharmaceutical compositions containing 2-substituted quinoxa lines
GB5293673A Expired GB1457005A (en) 1972-11-20 1973-11-14 2-substituted-3-aminoquinoxalines

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB5293673A Expired GB1457005A (en) 1972-11-20 1973-11-14 2-substituted-3-aminoquinoxalines

Country Status (5)

Country Link
JP (1) JPS554100B2 (https=)
DE (1) DE2357186A1 (https=)
FR (1) FR2206951B1 (https=)
GB (2) GB1457400A (https=)
NL (1) NL7315808A (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A7 (https=) * 1973-07-13 1975-01-14 Merck & Co Inc
DE2730644A1 (de) * 1977-07-07 1979-01-25 Bayer Ag Fluoreszenz-farbstoffe
WO1999042461A1 (en) * 1998-02-23 1999-08-26 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
JP4460450B2 (ja) 2002-06-19 2010-05-12 ビオヴィトルム・アクチボラゲット（プブリクト） 新規化合物、その使用および製造法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2107301A1 (de) * 1970-02-25 1971-09-09 CIBA Geigy AG, Basel (Schweiz) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
JPS554100B2 (https=) 1980-01-29
FR2206951B1 (https=) 1976-10-22
NL7315808A (https=) 1974-05-22
DE2357186A1 (de) 1974-05-22
FR2206951A1 (https=) 1974-06-14
GB1457005A (en) 1976-12-01
JPS49133384A (https=) 1974-12-21

Similar Documents

Publication Publication Date Title
GB1167736A (en) New N-Hydroxypyirimidines
GB1454778A (en) Therapeutic compositions comprising dioxamates
GB1260848A (en) Propanolamine derivatives
GB1457400A (en) Pharmaceutical compositions containing 2-substituted quinoxa lines
ES359454A1 (es) Procedimiento de preparacion de nuevos esteres aminoalcohi-lados de acidos anilino-2 nicotinico.
GB1260768A (en) N-alkyl-tetrahydrocarbazoles
GB1274652A (en) Adamantanyl-alkylamine derivatives and their preparation
GB1367785A (en) 2-substituted adenosine derivatives and the production thereof
GB1198283A (en) Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same
GB1181284A (en) Pteridinone Derivatives
GB1322451A (en) 3-amino-5-benzyl-1,2,4-oxadiazoles
GB1394757A (en) Lysino-calcium chloride
GB1281437A (en) Urea derivatives
GB1500962A (en) Furo(2,3-d)pyrimidine derivatives
GB1181967A (en) Novel Picoline Derivatives and a Method for the Production Thereof
GB1175617A (en) Substituted Pteridine Derivatives
GB1514225A (en) Paracetamol derivatives
GB1250348A (https=)
GB1156781A (en) New Heterocyclic Compounds
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
GB1175907A (en) Substituted Pteridine Derivatives
GB1254270A (en) Benzoxazepine derivatives
GB1531781A (en) N-propargyl-piperonylamine and its preparation and use
GB1354734A (en) Pharmaceutical compositions comprising aminoguanidine derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee